| Year |
Citation |
Score |
| 2020 |
Smith TT, Koopmeiners JS, White CM, Denlinger-Apte RL, Pacek LR, De Jesús VR, Wang L, Watson C, Blount BC, Hatsukami DK, Benowitz NL, Donny EC, Carpenter MJ. The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32102910 DOI: 10.1158/1055-9965.Epi-19-0963 |
0.332 |
|
| 2020 |
Smith TT, Koopmeiners JS, Hatsukami DK, Tessier KM, Benowitz NL, Murphy SE, Strasser AA, Tidey JW, Blount BC, Valentin L, Bravo Cardenas R, Watson C, Pirkle JL, Donny EC. Mouth-Level Nicotine Intake Estimates from Discarded Filter Butts to Examine Compensatory Smoking in Low Nicotine Cigarettes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32102909 DOI: 10.1158/1055-9965.Epi-19-0905 |
0.319 |
|
| 2020 |
Kotalik A, Vock DM, Donny EC, Hatsukami DK, Koopmeiners JS. Dynamic borrowing in the presence of treatment effect heterogeneity. Biostatistics (Oxford, England). PMID 31977040 DOI: 10.1093/Biostatistics/Kxz066 |
0.302 |
|
| 2020 |
Kaizer AM, Koopmeiners JS. A fully Bayesian mixture model approach for identifying noncompliance in a regulatory tobacco clinical trial. Statistics in Medicine. PMID 31961448 DOI: 10.1002/Sim.8478 |
0.356 |
|
| 2019 |
Smith TT, Donny EC, Luo X, Allen AM, Carroll DM, Denlinger-Apte RL, Dermody SS, Koopmeiners JS, McClernon FJ, Pacek LR, Vandrey R, Hatsukami DK. The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette Ratings. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 21: S73-S80. PMID 31867651 DOI: 10.1093/Ntr/Ntz158 |
0.31 |
|
| 2019 |
Koopmeiners JS, Vock DM, Boatman JA, Carroll D, Colby SM, Donny EC, Hatsukami DK, Luo X, Tidey JW. The Importance of Estimating Causal Effects for Evaluating a Nicotine Standard for Cigarettes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 21: S22-S25. PMID 31867648 DOI: 10.1093/Ntr/Ntz119 |
0.357 |
|
| 2019 |
Denlinger-Apte RL, Kotlyar M, Koopmeiners JS, Tidey JW, Luo X, Benowitz NL, Jensen JA, Ikuemonisan JO, Pacek LR, Smith TT, Vandrey R, Donny EC, Hatsukami DK. Effects of Very Low Nicotine Content Cigarettes on Smoking Behavior and Biomarkers of Exposure in Menthol and Non-menthol Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 21: S63-S72. PMID 31867637 DOI: 10.1093/Ntr/Ntz160 |
0.306 |
|
| 2019 |
Smith TT, Koopmeiners JS, Tessier KM, Davis EM, Conklin CA, Denlinger-Apte RL, Lane T, Murphy SE, Tidey JW, Hatsukami DK, Donny EC. Randomized Trial of Low-Nicotine Cigarettes and Transdermal Nicotine. American Journal of Preventive Medicine. 57: 515-524. PMID 31542129 DOI: 10.1016/J.Amepre.2019.05.010 |
0.314 |
|
| 2019 |
Hatsukami DK, Luo X, Heskin AK, Tang MK, Carmella SG, Jensen J, Robinson JD, Vandrey R, Drobes DJ, Strasser AA, al'Absi M, Leischow S, Cinciripini PM, Koopmeiners J, Ikuemonisan J, et al. Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects. Addiction (Abingdon, England). PMID 31140663 DOI: 10.1111/Add.14695 |
0.332 |
|
| 2019 |
Leng E, Henriksen JC, Rizzardi AE, Jin J, Nam JW, Brassuer BM, Johnson AD, Reder NP, Koopmeiners JS, Schmechel SC, Metzger GJ. Signature maps for automatic identification of prostate cancer from colorimetric analysis of H&E- and IHC-stained histopathological specimens. Scientific Reports. 9: 6992. PMID 31061447 DOI: 10.1038/S41598-019-43486-Y |
0.349 |
|
| 2019 |
Nardone N, Benowitz NL, Smith TT, Denlinger-Apte R, Hatsukami DK, Koopmeiners JS, Ren Y, Donny EC. Reasons for Non-compliance in a Trial of Reduced Nicotine Cigarettes Tobacco Regulatory Science. 5: 87-93. DOI: 10.18001/Trs.5.1.8 |
0.32 |
|
| 2018 |
Denlinger-Apte RL, Tidey JW, Koopmeiners JS, Hatsukami DK, Smith TT, Pacek LR, McClernon FJ, Donny EC. Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes. Tobacco Control. PMID 30385649 DOI: 10.1136/Tobaccocontrol-2018-054622 |
0.303 |
|
| 2018 |
Hatsukami DK, Luo X, Jensen JA, al'Absi M, Allen SS, Carmella SG, Chen M, Cinciripini PM, Denlinger-Apte R, Drobes DJ, Koopmeiners JS, Lane T, Le CT, Leischow S, Luo K, et al. Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial. Jama. 320: 880-891. PMID 30193275 DOI: 10.1001/Jama.2018.11473 |
0.336 |
|
| 2018 |
Jin J, Zhang L, Leng E, Metzger GJ, Koopmeiners JS. Detection of prostate cancer with multiparametric MRI utilizing the anatomic structure of the prostate. Statistics in Medicine. PMID 29923345 DOI: 10.1002/Sim.7810 |
0.353 |
|
| 2018 |
Cassidy RN, Tidey JW, Cao Q, Colby SM, McClernon FJ, Koopmeiners JS, Hatsukami D, Donny EC. Age Moderates Smokers' Subjective Response to Very Low Nicotine Content Cigarettes: Evidence from a Randomized Controlled Trial. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 29718460 DOI: 10.1093/Ntr/Nty079 |
0.317 |
|
| 2018 |
Leng E, Spilseth B, Zhang L, Jin J, Koopmeiners JS, Metzger GJ. Development of a measure for evaluating lesion-wise performance of CAD algorithms in the context of mpMRI detection of prostate cancer. Medical Physics. PMID 29542824 DOI: 10.1002/Mp.12861 |
0.307 |
|
| 2017 |
Pacek LR, Joseph McClernon F, Denlinger-Apte RL, Mercincavage M, Strasser AA, Dermody SS, Vandrey R, Smith TT, Nardone N, Hatsukami DK, Koopmeiners JS, Kozink RV, Donny EC. Perceived nicotine content of reduced nicotine content cigarettes is a correlate of perceived health risks. Tobacco Control. PMID 28735272 DOI: 10.1136/Tobaccocontrol-2017-053689 |
0.31 |
|
| 2017 |
Boatman JA, Vock DM, Koopmeiners JS, Donny EC. Estimating causal effects from a randomized clinical trial when noncompliance is measured with error. Biostatistics (Oxford, England). PMID 28605411 DOI: 10.1093/Biostatistics/Kxx029 |
0.337 |
|
| 2017 |
Kaizer AM, Koopmeiners JS. Identifying optimal approaches to early termination in two‐stage biomarker validation studies Journal of the Royal Statistical Society Series C-Applied Statistics. 66: 187-199. DOI: 10.1111/Rssc.12163 |
0.33 |
|
| 2016 |
Denlinger RL, Smith TT, Murphy SE, Koopmeiners JS, Benowitz NL, Hatsukami DK, Pacek LR, Colino C, Cwalina SN, Donny EC. Nicotine and Anatabine Exposure from Very Low Nicotine Content Cigarettes. Tobacco Regulatory Science. 2: 186-203. PMID 29600258 DOI: 10.18001/Trs.2.2.9 |
0.31 |
|
| 2016 |
Rupprecht LE, Koopmeiners JS, Dermody SS, Oliver JA, al'Absi M, Benowitz NL, Denlinger-Apte R, Drobes DJ, Hatsukami D, McClernon FJ, Pacek LR, Smith TT, Sved AF, Tidey J, Vandrey R, et al. Reducing nicotine exposure results in weight gain in smokers randomised to very low nicotine content cigarettes. Tobacco Control. PMID 27856940 DOI: 10.1136/Tobaccocontrol-2016-053301 |
0.303 |
|
| 2016 |
Pacek LR, Vandrey R, Dermody SS, Denlinger-Apte RL, Lemieux A, Tidey JW, McClernon FJ, Bangdiwala AS, Drobes DJ, al'Absi M, Strasser AA, Koopmeiners JS, Hatsukami DK, Donny EC. Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use. Drug and Alcohol Dependence. PMID 27590743 DOI: 10.1016/J.Drugalcdep.2016.08.620 |
0.31 |
|
| 2016 |
Cunanan KM, Koopmeiners JS. A Bayesian adaptive phase I-II trial design for optimizing the schedule of therapeutic cancer vaccines. Statistics in Medicine. PMID 27545299 DOI: 10.1002/Sim.7087 |
0.301 |
|
| 2016 |
Nardone N, Donny EC, Hatsukami DK, Koopmeiners JS, Murphy SE, Strasser AA, Tidey JW, Vandrey R, Benowitz NL. Estimations and Predictors of Non-Compliance in Switchers to Reduced Nicotine Content Cigarettes. Addiction (Abingdon, England). PMID 27367436 DOI: 10.1111/Add.13519 |
0.345 |
|
| 2016 |
Metzger GJ, Kalavagunta C, Spilseth B, Bolan PJ, Li X, Hutter D, Nam JW, Johnson AD, Henriksen JC, Moench L, Konety B, Warlick CA, Schmechel SC, Koopmeiners JS. Detection of Prostate Cancer: Multiparametric MR Imaging Models Developed by Using Registered Correlative Histopathologic Results. Radiology. 151089. PMID 26761720 DOI: 10.1148/Radiol.2015151089 |
0.326 |
|
| 2015 |
Koopmeiners JS, Feng Z. Group sequential testing of the predictive accuracy of a continuous biomarker with unknown prevalence. Statistics in Medicine. PMID 26537180 DOI: 10.1002/Sim.6790 |
0.496 |
|
| 2015 |
Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, al'Absi M, Carmella SG, Cinciripini PM, Dermody SS, Drobes DJ, Hecht SS, Jensen J, Lane T, Le CT, et al. Randomized Trial of Reduced-Nicotine Standards for Cigarettes. The New England Journal of Medicine. 373: 1340-1349. PMID 26422724 DOI: 10.1056/Nejmsa1502403 |
0.308 |
|
| 2015 |
Hatsukami DK, Donny EC, Koopmeiners JS, Benowitz NL. Compensatory smoking from gradual and immediate reduction in cigarette nicotine content. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 472-6. PMID 25515551 DOI: 10.1158/1055-9965.Epi-14-0739 |
0.314 |
|
| 2014 |
Rizzardi AE, Rosener NK, Koopmeiners JS, Isaksson Vogel R, Metzger GJ, Forster CL, Marston LO, Tiffany JR, McCarthy JB, Turley EA, Warlick CA, Henriksen JC, Schmechel SC. Evaluation of protein biomarkers of prostate cancer aggressiveness. Bmc Cancer. 14: 244. PMID 24708576 DOI: 10.1186/1471-2407-14-244 |
0.344 |
|
| 2013 |
Carlin BP, Zhong W, Koopmeiners JS. Discussion of 'small-sample behavior of novel phase I cancer trial designs' by Assaf P Oron and Peter D Hoff. Clinical Trials (London, England). 10: 81-5; discussion 88-. PMID 23345305 DOI: 10.1177/1740774512469313 |
0.306 |
|
| 2013 |
Zhong W, Carlin BP, Koopmeiners JS. Flexible link continual reassessment methods for trivariate binary outcome phase I/II Trials Journal of Statistical Theory and Practice. 7: 442-455. DOI: 10.1080/15598608.2013.772815 |
0.313 |
|
| 2012 |
Zhong W, Koopmeiners JS, Carlin BP. A trivariate continual reassessment method for phase I/II trials of toxicity, efficacy, and surrogate efficacy. Statistics in Medicine. 31: 3885-95. PMID 22807126 DOI: 10.1002/Sim.5477 |
0.309 |
|
| 2012 |
Koopmeiners JS, Feng Z, Pepe MS. Conditional estimation after a two-stage diagnostic biomarker study that allows early termination for futility. Statistics in Medicine. 31: 420-35. PMID 22238117 DOI: 10.1002/Sim.4430 |
0.47 |
|
| 2011 |
Koopmeiners JS, Feng Z. Asymptotic Properties of the Sequential Empirical ROC, PPV and NPV Curves Under Case-Control Sampling. Annals of Statistics. 39: 3234-3261. PMID 24039313 DOI: 10.1214/11-Aos937 |
0.469 |
|
| 2010 |
Holt SK, Kwon EM, Koopmeiners JS, Lin DW, Feng Z, Ostrander EA, Peters U, Stanford JL. Vitamin D pathway gene variants and prostate cancer prognosis. The Prostate. 70: 1448-60. PMID 20687218 DOI: 10.1002/Pros.21180 |
0.479 |
|
| 2010 |
Wright JL, Kwon EM, Lin DW, Kolb S, Koopmeiners JS, Feng Z, Ostrander EA, Stanford JL. CYP17 polymorphisms and prostate cancer outcomes. The Prostate. 70: 1094-101. PMID 20503394 DOI: 10.1002/Pros.21143 |
0.509 |
|
| 2010 |
Langeberg WJ, Kwon EM, Koopmeiners JS, Ostrander EA, Stanford JL. Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 258-64. PMID 20056646 DOI: 10.1158/1055-9965.Epi-09-0800 |
0.342 |
|
| 2009 |
Wright JL, Salinas CA, Lin DW, Kolb S, Koopmeiners J, Feng Z, Stanford JL. Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. The Journal of Urology. 182: 2702-7. PMID 19836772 DOI: 10.1016/J.Juro.2009.08.026 |
0.514 |
|
| 2009 |
Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, ... ... Koopmeiners JS, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nature Genetics. 41: 1116-21. PMID 19767753 DOI: 10.1038/Ng.450 |
0.343 |
|
| 2009 |
Fitzgerald LM, Kwon EM, Koopmeiners JS, Salinas CA, Stanford JL, Ostrander EA. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3231-7. PMID 19366831 DOI: 10.1158/1078-0432.Ccr-08-2190 |
0.34 |
|
| 2009 |
Pepe MS, Feng Z, Longton G, Koopmeiners J. Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility. Statistics in Medicine. 28: 762-79. PMID 19097251 DOI: 10.1002/Sim.3506 |
0.471 |
|
| 2009 |
Salinas CA, Koopmeiners JS, Kwon EM, FitzGerald L, Lin DW, Ostrander EA, Feng Z, Stanford JL. Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. The Prostate. 69: 363-72. PMID 19058137 DOI: 10.1002/Pros.20887 |
0.512 |
|
| 2009 |
FitzGerald LM, Karlins E, Karyadi DM, Kwon EM, Koopmeiners JS, Stanford JL, Ostrander EA. Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis. Prostate Cancer and Prostatic Diseases. 12: 192-7. PMID 18762813 DOI: 10.1038/Pcan.2008.46 |
0.353 |
|
| 2009 |
Wright JL, Lin DW, Kwon EM, Kolb S, Feng Z, Koopmeiners J, Ostrander EA, Stanford JL. CYP17 POLYMORPHISMS AND PROSTATE CANCER OUTCOMES Journal of Urology. 181: 777-777. DOI: 10.1016/S0022-5347(09)62164-9 |
0.503 |
|
| 2008 |
Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, Ingles SA, Schaid D, Thibodeau S, Dörk T, Neal D, Donovan J, Hamdy F, Cox A, Maier C, Vogel W, ... ... Koopmeiners JS, et al. Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 2052-61. PMID 18708398 DOI: 10.1158/1055-9965.Epi-08-0317 |
0.343 |
|
| 2008 |
Salinas CA, Kwon E, Carlson CS, Koopmeiners JS, Feng Z, Karyadi DM, Ostrander EA, Stanford JL. Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1203-13. PMID 18483343 DOI: 10.1158/1055-9965.Epi-07-2811 |
0.487 |
|
| Show low-probability matches. |